Last $21.88 USD
Change Today +0.31 / 1.44%
Volume 699.0K
SRPT On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - SAREPTA THERAPEUTICS INC (SRPT)

Sarepta Therapeutics, Inc. to Report Q1, 2014 on May 08, 2014
CapIQ 05/08/2014 1:00 PM ET
Sarepta Therapeutics, Inc. to Report Q4, 2013 on Feb 27, 2014
CapIQ 05/08/2014 1:00 PM ET
Sarepta Therapeutics, Inc. to Report Q3, 2013 on Nov 12, 2013
CapIQ 05/08/2014 1:00 PM ET

2013 revenues at Sarepta Therapeutics, Inc. totaled $14.2M USD, while annual losses equaled $2.63 per share.

Quarterly Earnings & Estimates - SAREPTA THERAPEUTICS INC (SRPT)

Actuals vs. Estimates for SAREPTA THERAPEUTICS INC SRPT

Sarepta Therapeutics, Inc.'s Quarterly Earnings

Sarepta Therapeutics, Inc. reported 1st quarter 2014 losses of $0.55 per share on 05/10/2014.

Annual Earnings & Estimates - SAREPTA THERAPEUTICS INC (SRPT)

Actuals vs. Estimates for SAREPTA THERAPEUTICS INC SRPT

Sarepta Therapeutics, Inc.'s Annual Earnings

Sarepta Therapeutics, Inc. reported annual 2013 losses of $2.63 per share on 03/1/2014.

Quarterly Revenues - SAREPTA THERAPEUTICS INC (SRPT)

Actuals vs. Estimates for SAREPTA THERAPEUTICS INC SRPT

Sarepta Therapeutics, Inc.'s Quarterly Revenues

Sarepta Therapeutics, Inc. had 1st quarter 2014 revenues of $6.1M USD. This bettered the $3.5M USD consensus of the 14 analysts covering the company. This was 36.1% above the prior year's 1st quarter results.

Annual Revenues - SAREPTA THERAPEUTICS INC (SRPT)

Actuals vs. Estimates for SAREPTA THERAPEUTICS INC SRPT

Sarepta Therapeutics, Inc.'s Annual Revenues

Sarepta Therapeutics, Inc. had revenues for the full year 2013 of $14.2M USD. This was -61.9% below the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SRPT:US $21.88 USD +0.31

SRPT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AstraZeneca PLC 4,411 GBp -15.00
Baxter International Inc $76.87 USD +0.76
Gilead Sciences Inc $89.33 USD +0.47
Hemispherx Biopharma Inc $0.27 USD +0.011
SciClone Pharmaceuticals Inc $5.12 USD +0.14
View Industry Companies
 

Industry Analysis

SRPT

Industry Average

Valuation SRPT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 51.5x
Price/Book 3.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 41.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAREPTA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.